Literature DB >> 25162308

Hepatocellular carcinoma: surveillance CT schedule after hepatectomy based on risk stratification.

Dan Liu1, Daniel Y T Fong, Albert C Y Chan, Ronnie T P Poon, Pek-Lan Khong.   

Abstract

PURPOSE: To evaluate alternative schedules for surveillance computed tomography (CT) for patients who underwent hepatectomy for hepatocellular carcinoma ( HCC hepatocellular carcinoma ) and to demonstrate an appropriate schedule on the basis of stratification for risk of recurrence.
MATERIALS AND METHODS: CT and pathologic reports for consecutive patients with HCC hepatocellular carcinoma who underwent hepatectomy at one institution were evaluated with institutional review board approval. Univariate and multivariate analyses were performed to identify risk factors for recurrence. Patients were categorized into risk groups on the basis of classification and regression tree analysis. Average recurrence detection rates ( RDR recurrence detection rate s) between consecutive CT scans were calculated for existing and alternative surveillance schedules for each risk group, and the difference in RDR recurrence detection rate was determined by using the Student t test. A P value of less than .05 was considered to indicate a significant difference. Expected delay in diagnosis was also computed for the alternative surveillance schedules for each risk group.
RESULTS: Two hundred sixty patients (216 men; mean age, 56.0 years ± 22.5) underwent 2705 CT studies. Independent risk factors for recurrence were microvascular invasion (P = .001), cirrhosis (P = .007), and tumor multiplicity (P = .001). Three risk groups (low, intermediate, and high) were identified. For low- and intermediate-risk groups, average RDR recurrence detection rate was not significantly different in the first 2 years after hepatectomy when the interval was extended from 3 months (3.3% and 4.6%, respectively) to 4 months (4.3% [expected delay, 16 days] and 6.1% [expected delay, 18 days], respectively) or for the subsequent 3 years when the interval was extended from 6 months (1.3% and 3.5%, respectively) to 12 months (2.5% [expected delay, 72 days] and 7.0% [expected delay, 103 days], respectively). This alternative schedule included five (35.7%) fewer CT scans than the 14 in the original schedule, and a reduction in radiation dose and cost during the 5-year follow-up period.
CONCLUSION: Posthepatectomy surveillance CT schedules may be tailored and optimized according to stratification by risk of recurrence to reduce the frequency of CT scans without compromising surveillance benefits.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25162308     DOI: 10.1148/radiol.14132343

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  Does a combined CT and MRI protocol enhance the diagnostic efficacy of LI-RADS in the categorization of hepatic observations? A prospective comparative study.

Authors:  Mohammad Abd Alkhalik Basha; Mohamad Zakarya AlAzzazy; Ayman F Ahmed; Hala Y Yousef; Samar Mohamad Shehata; Dena Abd El Aziz El Sammak; Talaat Fathy; Ahmed Ali Obaya; Eman H Abdelbary
Journal:  Eur Radiol       Date:  2018-01-24       Impact factor: 5.315

Review 2.  Intrahepatic recurrence of hepatocellular carcinoma after resection: an update.

Authors:  Maria Tampaki; George Vasileios Papatheodoridis; Evangelos Cholongitas
Journal:  Clin J Gastroenterol       Date:  2021-03-27

3.  A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma.

Authors:  Wenyu Gao; Wentao Wang; Danjun Song; Chun Yang; Kai Zhu; Mengsu Zeng; Sheng-Xiang Rao; Manning Wang
Journal:  Radiol Med       Date:  2022-02-07       Impact factor: 3.469

4.  Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center.

Authors:  Kit-Fai Lee; Charing C N Chong; Anthony K W Fong; Andrew K Y Fung; Hon-Ting Lok; Yue-Sun Cheung; John Wong; Paul B S Lai
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

5.  Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study.

Authors:  Wei He; Yun Zheng; Ruhai Zou; Jingxian Shen; Junping Yang; Jiliang Qiu; Qiang Tao; Wenwu Liu; Zhiwen Yang; Yuanping Zhang; Binkui Li; Yunfei Yuan
Journal:  Cancer Commun (Lond)       Date:  2018-05-21

6.  Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification.

Authors:  Xuqi Sun; Lingling Li; Ning Lyu; Luwen Mu; Jinfa Lai; Ming Zhao
Journal:  Cancer Imaging       Date:  2020-07-01       Impact factor: 3.909

7.  Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation.

Authors:  Wenwu Liu; Yun Zheng; Ruhai Zou; Jingxian Shen; Wei He; Zhiwen Yang; Yuanping Zhang; Binkui Li; Yunfei Yuan
Journal:  BMC Cancer       Date:  2018-11-29       Impact factor: 4.430

8.  Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response.

Authors:  Azeez Osho; Nicole E Rich; Amit G Singal
Journal:  Hepatoma Res       Date:  2020-08-27

Review 9.  Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review.

Authors:  Sami Akbulut; Ibrahim Umar Garzali; Abdirahman Sakulen Hargura; Ali Aloun; Sezai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2022-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.